Entod Pharmaceuticals, a leader in ophthalmology, ENT, and dermatology medicines, has announced a number of innovative changes among its specialty divisions that will help to strengthen India’s position in global pharmaceutical R&D.
The Kerala branch of the Indian Pharmaceutical Association (IPA) is launching a series of training programs over the next year to boost the skills of pharmacy students, working pharmacists, and other professionals in the field...
High-quality pDNA is a primary source of genetic information for the development of life-saving therapies, but the current manufacturing processes have limitations regarding scalability, efficiency, and cost. This project combines WACKER's expertise
German specialty glass maker Schott announced the expansion of syringe and cartridge glass tubing capabilities at its newly opened facility in Jambusar, Gujarat
Zepto, quick commerce leader has now entered the pharmacy retail space with Zepto Pharmacy and is promoting 10-minute medicine delivery in select metropolitan markets.
Apollo Ayurveda, India’s most well-known chain of precision Ayurveda hospitals and a leader in integrative medicine has entered into a Memorandum of Understanding (MOU) with the Jawaharlal Nehru Tropical Botanic Garden and Research Institute (JNTBGR
Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets
In a move that blends generative AI with healthcare delivery, ekincare has announced the launch of elva.AI, an always-on, intelligent Gen-AI assistant designed to deliver instant, personalized support across pharmacy, checkups, reimbursements...
The Pharma Manufacturing and Automation Convention 2025 is about to take place on October 8 and 9, at Hotel Novotel HICC, Hyderabad. This two-day event will unite pharma innovators, leaders in Mfg and digital visionaries to recreate the manner...
Roche reported positive five-year effectiveness, safety, and durability data for Susvimo (ranibizumab injection) for the treatment of neovascular or "wet" age-related macular degeneration (nAMD) from the Phase III Portal study, a long-term extension
.jpg)
.jpg)
, CDSCO.jpg)